Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alternativeName |
GG-545
N-(2,6-dimethylphenyl)-2-[(4-methyl-1-piperazinyl)methyl]benzamide |
| gptkbp:chemicalFormula |
C20H25N3O
|
| gptkbp:drugClass |
benzodiazepine
|
| gptkbp:has_studied_effect |
anxiolytic effect in animal studies
|
| https://www.w3.org/2000/01/rdf-schema#label |
GG 545
|
| gptkbp:legalStatus |
not approved for medical use
|
| gptkbp:mechanismOfAction |
GABAA receptor positive allosteric modulator
|
| gptkbp:molecularWeight |
323.43 g/mol
|
| gptkbp:relatedTo |
benzodiazepine
|
| gptkbp:bfsParent |
gptkb:Monforte_Altarpiece
|
| gptkbp:bfsLayer |
7
|